Michael H. Davidson - Jan 1, 2024 Form 4 Insider Report for NewAmsterdam Pharma Co N.V. (NAMS)

Role
Chief Executive Officer, Director
Signature
/s/ Louise Kooij by Power of Attorney from Michael H. Davidson
Stock symbol
NAMS
Transactions as of
Jan 1, 2024
Transactions value $
$0
Form type
4
Date filed
1/3/2024, 05:14 PM
Previous filing
Jan 25, 2024
Next filing
Sep 27, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NAMS Option (right to buy) Award $0 +1.04M $0.00 1.04M Jan 1, 2024 Ordinary Shares 1.04M $11.17 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying the option will vest on January 1, 2025, the one-year anniversary of vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date.